The Intrauterine Device: Rethinking Old Paradigms

Journal of Midwifery and Women's Health

Volumn 51, Issue 6, 2006, Pages 464-470

  Morgan, Katherine W ^a  

^a NONE

Author keywords

contraception; contraceptive devices: intrauterine; contraceptive devices: medicated; contraceptive devices: unmedicated

Indexed keywords

ANTIRETROVIRUS AGENT; COPPER INTRAUTERINE DEVICE; GESTAGEN; LEVONORGESTREL; LIDOCAINE; MISOPROSTOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMENORRHEA; ARTICLE; BIRTH CONTROL; BREAST CANCER; CLINICAL PRACTICE; CONTRACEPTION; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DEVELOPED COUNTRY; DYSMENORRHEA; ECTOPIC PREGNANCY; FAMILY PLANNING; FEMALE; FEMALE INFERTILITY; FOLLICLE CYST; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERMENORRHEA; INDUCED ABORTION; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; ISCHEMIC HEART DISEASE; LIVER CANCER; LIVER CIRRHOSIS; LUNG EMBOLISM; MARRIAGE; MEDICAL INFORMATION; MENSTRUAL CYCLE; MIGRAINE WITH AURA; OVARY CANCER; PARITY; PATIENT SAFETY; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RISK ASSESSMENT; RISK REDUCTION; SEXUALLY TRANSMITTED DISEASE; TREATMENT CONTRAINDICATION; TROPHOBLASTIC TUMOR; UNITED STATES; UTERUS PERFORATION;

CONTRACEPTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, COPPER; INTRAUTERINE DEVICES, MEDICATED; UNITED STATES; WOMEN'S HEALTH;

EID: 33750330673     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2006.06.008     Document Type: Article

References (39)

1. Arias R. Compelling reasons for recommending IUDs to women of any reproductive age. Int J Fertil Womens Med 47 (2002) 87-95
2. Stanwood N., Garrett J., and Konrad T. Obstetrician-gynecologists and the intrauterine device: A survey of attitudes and practice. Obstet Gynecol 99 (2002) 1135-1136
3. FDA approves ParaGard IUD for women who have not had children. PRNewswire. Available from: www.paragard.com%20 [Accessed September 13, 2005].
4. Tone A. Devices and desires: A history of contraceptives in America (2001), Hill & Wong, New York
5. Hubacher D., and Cheng D. Intrauterine devices and reproductive health: American women in feast and famine. Contraception 69 (2004) 437-446
6. Nelson A. The intrauterine contraceptive device. Obstet Gynecol Clin North Am 27 (2000) 723-740
7. Grimes D.A. Intrauterine device and upper-genital-tract infection. Lancet 356 (2000) 1013-1019
8. Kessel E. Pelvic inflammatory disease with intrauterine device use: A reassessment. Fertl Sertil 51 (1989) 1-11
9. World Health Organization. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception 56 (1997) 341-352
10. Sivin I., Stern J., Coutinho E., el Mahgoub S., Diaz S., Pavez M., et al. Prolonged intrauterine contraception: A seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception 44 (1991) 473-480
11. Luukkainen T. The levonorgestrel-releasing intrauterine system: Therapeutic aspects. Steroids 65 (2000) 699-702
12. Majorbanks J., Lethaby A., and Fahrquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Systematic Review CS003855 (2003)
13. Wildemeersch D., Janssens D., Schacht E., Pylyser K., and deWeyer N. Intrauterine levonorgestrel delivered by a framelss system, combined with systemic estrogen: Acceptability and endometrial safety after 3 years of use in peri-and postmenopausal women. Gynecol Endocrinol 20 (2005) 336-342
14. Peterson H.B., Xia Z., Hughes J.M., Wilcox L.S., Tylor L.R., and Trussell J. The risk of pregnancy after tubal sterilization: Findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 174 (1996) 1161-1168
15. Hatcher R.A., Trussell J., Stewart F., Nelson A.L., Cates W., Guest F., and Kowal D. Contraceptive technology (2005), Ardent Media, New York 497
16. Hill D.A., Weiss N.S., Voigt L., and Beresford S.A. Endometrial cancer in relation to intra-uterine device use. Int J Cancer 70 (1997) 278-281
17. Vereide A.B., Arnes M., Straume B., Maltau J.M., and Orbo A. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: A study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol Oncol 91 (2003) 526-533
18. Ortiz M.E., Croxatto H.B., and Bardin C.W. Mechanisms of action of intrauterine devices. Obstet Gynecol Survey 51 12 suppl (1996) S42-S51
19. Rivera R., Yacobson I., and Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 181 pt 1 (1999) 1263-1269
20. Alvarez F., Brache V., Fernandez E., Guerrero B., Guiloff E., Hess R., et al. New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril 49 (1988) 768-773
21. Xiong X., Buekens P., and Wollast E. IUD use and the risk of ectopic pregnancy: A meta-analysis of case controlled studies. Contraception 52 (1995) 23-34
22. Stanford J., and Mikolajczyk R.T. Mechanisms of actions of intrauterine devices: Update and estimation of postfertilization effects. Am J Obstet Gynecol 187 (2002) 1699-1708
23. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd ed (2004), World Health Organization, Geneva
24. Farley T.M., Rosenberg M.J., Rowe P.J., Chen J.H., and Meirik O. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1 (1992) 785-788
25. Grimes DA, Schulz FK. Antibiotic prophylaxis for intrauterine contraceptive device insertion (Cochrane Review). In: The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons.
26. American College of Obstetricians and Gynecologists. Intrauterine Device. ACOG Practice Bulletin No. 59. Obstet Gynecol 105 (2005) 223-232
27. Caliskan E., Ozturk N., Dilbaz B.O., and Dilbaz S. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 8 (2003) 150-155
28. Farmer M., and Webb A. Intrauterine device insertion-related complications: Can they be predicted?. J Fam Plann Reprod Health Care 29 (2003) 227-231
29. Andersson K., Odlind V., and Rybo G. Levonorgestrel-relaeasing and copper releasing (Nova-T) IUDs during five years of use: A randomized comparative trial. Contraception 49 (1994) 56-72
30. Pakarinen P.I., Suvisaari J., Luukkainen T., and Lahteenmaki P. Intracervical and fundal administration of levonorgestrel for contraception: Endometrial thickness, patterns of bleeding, and persisting ovarian follicles. Fertil Steril 68 (1997) 59-64
31. Li C.I., Lee S.S.N., and Pun T.C. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single nulliparous Chinese females following surgical abortion. Contraception 69 (2004) 247-250
32. Herndon E.J., and Zieman M. New contraceptive options. Am Fam Phys 69 (2004) 855-860
33. Hubacher D., Lara-Ricald R., Taylor D.J., Guerra-Infante F., and Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 345 (2001) 561-567
34. Suhonen S., Haukkamaa M., Jakobsson T., and Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study. Contraception 69 (2004) 407-412
35. Espey E., and Ogburn T. Perpetuating negative attitudes about the intrauterine device: Textbooks lag behind the evidence. Contraception 65 (2002) 389-395
36. Weiss E., and Moore K. An assessment of the quality of information available on the internet about the IUD and the potential impact on contraceptive choices. Contraception 68 (2003) 359-364
37. Henshaw S.K. Unintended pregnancy in the United States. Fam Plann Perspect 30 (1998) 24-29 46
38. Bongaarts J., and Westoff C.F. The potential role of contraception in reducing abortion. Stud Fam Plann 31 (2000) 193-202
39. Hatcher R.A., Nelson A.L., Zieman M., Darney P.D., Crenin M.C., Stosur H.R., et al. A pocket guide to managing contraception (2002), Bridging the Gap Foundation, Tiger, GA